
What Is a Theranostic Wound Dressing?
A theranostic wound dressing does more than cover a cut—it actively detects infection and delivers targeted treatment. In this Bio Break episode, Nick and Nigel explore how this smart technology could transform chronic wound care for patients with conditions like diabetic foot ulcers.
How Theranostic Wound Dressings Work
This is no ordinary Band-Aid. While Nick jokes about having a stash of Pokémon bandages at home, this dressing prototype is designed for something much more serious—chronic wounds and diabetic foot ulcers, where early detection and timely treatment are essential.
The innovation lies in a visual infection indicator embedded within the dressing. When an infection is detected, the dressing can release an antimicrobial treatment directly into the wound site, offering a targeted therapeutic response before complications escalate.
Benefits of Theranostic Wound Dressings
Why is that important? Because antimicrobial stewardship is more critical than ever. Overusing broad-spectrum antibiotics or applying antimicrobials when they’re not needed contributes to resistance and unnecessary costs. This dressing applies treatment only when and where it’s required—no more, no less.
Of course, not every scrape or paper cut needs advanced diagnostics. Nick and Nigel discuss the use case limitations, noting this device wouldn’t make sense in your medicine cabinet at home. But in hospitals, long-term care centers, or for at-risk patients with chronic wounds, it could be a game changer.
The future of wearable MedTech is here, and it’s smarter than ever. Tune in to see how this dressing bridges diagnostics and therapy in one elegant solution—and where it might show up next.
Learn more about StarFish Medical.
Related Resources

Graphical mind maps created in online whiteboards offer a low-barrier, highly collaborative approach to early risk analysis in medical device development.

Early phase concept development is a weird part of a project lifecycle. It is often the most exciting phase, because the team is exploring possibilities, generating new ideas, and turning a fuzzy opportunity into something real.

Clinical prototypes must not only function as intended, but also be manufactured, documented, and supported in a way that satisfies regulatory expectations and clinical realities.

In this Bio Break episode, Nick and Nigel explore why some GLP-1 drugs are taken daily while others last a full week, and what drives that difference at a molecular level.